Insertion of Alzheimer's Aβ40 peptide into lipid monolayers

Biophysical Journal

Volumn 87, Issue 3, 2004, Pages 1732-1740

  Ege, Canay ^a   Lee, Ka Yee C ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOLYTE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; ANIONIC DIPALMITOYLPHOSPHATIDYLGLYCEROL; CATIONIC DIPALMITOYLTRIMETHYLAMMONIUM PROPANE; DIPALMITOYLPHOSPHATIDYLGLYCEROL; LIPID; MEMBRANE LIPID; PEPTIDE; PHOSPHOLIPID; PROPANE; PROTEIN; UNCLASSIFIED DRUG; ZWITTERIONIC DIPALMITOYLPHOSPHATIDYLCHOLINE;

ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; CHROMATOPHORE; FLUORESCENCE; FLUORESCENCE MICROSCOPY; LIPID BILAYER; LIPID MEMBRANE; LIPID MONOLAYER; PROTEIN AGGREGATION; PROTEIN INTERACTION; PROTEIN LIPID INTERACTION; SURFACE PROPERTY;

INSERTION SEQUENCES;

EID: 4444328762     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.104.043265     Document Type: Article

References (39)

1. Andelman, D., F. Brochard, and J. F. Joanny. 1987. Phase-transitions in Langmuir monolayers of polar-molecules. J. Chem. Phys. 86:3673-3681.
2. Arispe, N., E. Rojas, and H. B. Pollard. 1993. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA. 90:567-571.
3. Barrow, C. J., A. Yasuda, P. T. Kenny, and M. G. Zagorski. 1992. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J. Mol. Biol. 225:1075-1093.
4. Bokvist, M., F. Lindstrom, A. Watts, and G. Grobner. 2004. Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J. Mol. Biol. 335:1039-1049.
5. Bostrom, M., D. R. M. Williams, and B. W. Ninham. 2002. Influence of Hofmeister effects on surface pH and binding of peptides to membranes. Langmuir. 18:8609-8615.
6. Bucciantini, M., E. Giannoni, F. Chiti, F. Baroni, L. Formigli, J. Zurdo, N. Taddei, G. Ramponi, C. M. Dobson, and M. Stefani. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 416:507-511.
7. Chauhan, A., I. Ray, and V. P. Chauhan. 2000. Interaction of amyloid beta-protein with anionic phospholipids: possible involvement of Lys28 and C-terminus aliphatic amino acids. Neurochem. Res. 25:423-429.
8. Choo-Smith, L. P., W. Garzon-Rodriguez, C. G. Glabe, and W. K. Surewicz. 1997. Acceleration of amyloid fibril formation by specific binding of Abeta-(1-40) peptide to ganglioside-containing membrane vesicles. J. Biol. Chem. 272:22987-22990.
9. Coles, M., W. Bicknell, A. A. Watson, D. P. Fairlie, and D. J. Craik. 1998. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry. 37:11064-11077.
10. Diamant, H., T. A. Witten, C. Ege, A. Gopal, and K. Y. Lee. 2001. Topography and instability of monolayers near domain boundaries. Phys Rev E. 63:061602-061612.
11. Ege, C. 2004. Interaction of amyloid beta peptides with lipid membranes. PhD Thesis. The University of Chicago, Chicago.
12. Haass, C., and D. J. Selkoe. 1998. Alzheimer's disease. A technical KO of amyloid-beta peptide. Nature. 391:339-340.
13. Hanakam, F., G. Gerisch, S. Lotz, T. Alt, and A. Seelig. 1996. Binding of hisactophilin I and II to lipid membranes is controlled by a pH-dependent myristoyl-histidine switch. Biochemistry. 35:11036-11044.
14. Hardy, J. 1997. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:154-159.
15. Hirakura, Y., M. C. Lin, and B. L. Kagan. 1999. Alzheimer amyloid abeta1-42 channels: effects of solvent, pH, and Congo Red. J. Neurosci. Res. 57:458-466.
16. Kawahara, M., N. Arispe, Y. Kuroda, and E. Rojas. 1997. Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons. Biophys. J. 73:67-75.
17. Kirkitadze, M. D., G. Bitan, and D. B. Teplow. 2002. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J. Neurosci. Res. 69:567-577.
18. Knobler, C. M. 1990. Seeing phenomena in flatland-studies of monolayers by fluorescence microscopy. Science. 249:870-874.
19. Koppaka, V., and P. H. Axelsen. 2000. Accelerated accumulation of amyloid beta proteins on oxidatively damaged lipid membranes. Biochemistry. 39:10011-10016.
20. Kosik, K. S., C. L. Joachim, and D. J. Selkoe. 1986. Microtubule- associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 83: 4044-4048.
21. Kremer, J. J., D. J. Sklansky, and R. M. Murphy. 2001. Profile of changes in lipid bilayer structure caused by beta-amyloid peptide. Biochemistry. 40:8563-8571.
22. Lashuel, H. A., D. Hartley, B. M. Petre, T. Walz, and P. T. Lansbury, Jr. 2002. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature. 418:291-292.
23. Lin, H., Y. J. Zhu, and R. Lal. 1999. Amyloid beta protein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles. Biochemistry. 38:11189-11196.
24. Lorenzo, A., and B. A. Yankner. 1994. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. USA. 91:12243-12247.
25. Malinchik, S. B., H. Inouye, K. E. Szumowski, and D. A. Kirschner. 1998. Structural analysis of Alzheimer's beta(1-40) amyloid: protofilament assembly of tubular fibrils. Biophys. J. 74:537-545.
26. McLaurin, J., and A. Chakrabartty. 1997. Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes. Eur. J. Biochem. 245:355-363.
27. Naslund, J., V. Haroutunian, R. Mohs, K. L. Davis, P. Davies, P. Greengard, and J. D. Buxbaum. 2000. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA. 283:1571-1577.
28. Pike, C. J., D. Burdick, A. J. Walencewicz, C. G. Glabe, and C. W. Cotman. 1993. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1676-1687.
29. Seelig, A. 1987. Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers. Biochim. Biophys. Acta. 899: 196-204.
30. Selkoe, D. J. 1994. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10: 373-403.
31. Selkoe, D. J. 2000. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. N. Y. Acad. Sci. 924:17-25.
32. Seubert, P., C. Vigo-Pelfrey, F. Esch, M. Lee, H. Dovey, D. Davis, S. Sinha, M. Schlossmacher, J. Whaley, C. Swindlehurst, R. McCormak, R. Wolfbert, D. Selkoe, I. Lieberburg, and D. Schenk. 1992. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature. 359:325-327.
33. Shen, C. L., and R. M. Murphy. 1995. Solvent effects on self-assembly of beta-amyloid peptide. Biophys. J. 69:640-651.
34. Terzi, E., G. Holzemann, and J. Seelig. 1994. Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes. Biochemistry. 33:7434-7441.
35. Terzi, E., G. Holzemann, and J. Seelig. 1995. Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes. J. Mol. Biol. 252:633-642.
36. Terzi, E., G. Hölzemann, and J. Seelig. 1997. Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes. Biochemistry. 36: 14845-14852.
37. Vargas, J., J. M. Alarcon, and E. Rojas. 2000. Displacement currents associated with the insertion of Alzheimer disease amyloid beta-peptide into planar bilayer membranes. Biophys. J. 79:934-944.
38. Voiles, M. J., and P. T. Lansbury, Jr. 2003. Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease. Biochemistry. 42:7871-7878.
39. Yip, C. M., E. A. Elton, A. A. Darabie, M. R. Morrison, and J. McLaurin. 2001. Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity. J. Mol. Biol. 311:723-734.